TG THERAPEUTICS INC (TGTX) Stock Earnings & Estimates
NASDAQ:TGTX - US88322Q1085 - Common Stock
29.33 USD
+0.37 (+1.28%)
29.33 USD
0 (0%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 2.785M -58.36% | 233.662M 8,290.02% | 329.004M 40.80% | 600.69M 82.58% | 870.93M 44.99% | 1.109B 27.34% | 1.446B 30.39% | 1.681B 16.25% | 1.828B 8.74% | 2.204B 20.57% | 2.446B 10.98% | |
| EBITDA YoY % growth | -218.013M 36.71% | 20.844M 109.56% | 41.997M 101.48% | 149.54M 256.07% | 314.62M 110.39% | 336.78M 7.04% | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -218.316M 36.68% | 20.633M 109.45% | 41.929M 103.21% | 149.69M 257.01% | 328.02M 119.13% | 476.63M 45.31% | 746.5M 56.62% | 914.23M 22.47% | 1.001B 9.49% | 1.232B 23.08% | 1.395B 13.23% | |
| Operating Margin | -7,838.99% | 8.83% | 12.74% | 24.92% | 37.66% | 42.98% | 51.63% | 54.39% | 54.76% | 55.90% | 57.03% | |
| EPS YoY % growth | -1.46 44.49% | 0.01 100.68% | 0.14 1,300.00% | 0.80 470.71% | 1.87 134.47% | 2.45 30.81% | 3.59 46.51% | 4.51 25.57% | 4.38 -2.94% | 5.76 31.70% | N/A |
All data in USD
| Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 0.23 1,064.48% | 0.35 133.46% | 0.39 1,192.00% | 0.48 182.00% | 0.50 114.60% | 0.62 76.22% |
| Revenue Q2Q % growth | 156.01M 85.99% | 177.92M 64.46% | 191.05M 58.08% | 213.85M 51.51% | 232.95M 49.32% | 261.62M 47.04% |
| EBITDA Q2Q % growth | 56.549M 352.65% | 74.032M 146.63% | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | 42.855M 244.66% | 62.668M 109.25% | 73.554M 753.10% | 92.871M 166.54% | 95.268M 122.30% | 115.87M 84.90% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | 0.17 325.00% | 0.22 | -0.05 | -23.26% |
| Q1 2025 Q2Q % growth | 0.03 142.86% | 0.19 | -0.16 | -83.83% |
| Q4 2024 Q2Q % growth | 0.15 250.00% | 0.08 | 0.07 | 77.18% |
| Q3 2024 Q2Q % growth | 0.02 -97.26% | 0.03 | -0.01 | -33.53% |
| Q2 2024 Q2Q % growth | 0.04 111.76% | -0.05 | 0.09 | 185.79% |
| Q1 2024 Q2Q % growth | -0.07 75.00% | -0.04 | -0.03 | -92.18% |
| Q4 2023 Q2Q % growth | -0.10 74.36% | -0.11 | 0.01 | 5.99% |
| Q3 2023 Q2Q % growth | 0.73 380.77% | 0.12 | 0.61 | 518.52% |
| Q2 2023 Q2Q % growth | -0.34 -13.33% | -0.25 | -0.09 | -34.00% |
| Q1 2023 Q2Q % growth | -0.28 45.10% | -0.37 | 0.09 | 25.23% |
| Q4 2022 Q2Q % growth | -0.39 44.29% | -0.27 | -0.12 | -47.06% |
| Q3 2022 Q2Q % growth | -0.26 60.00% | -0.35 | 0.09 | 25.34% |
| Q2 2022 Q2Q % growth | -0.30 49.15% | -0.52 | 0.22 | 42.33% |
| Q1 2022 Q2Q % growth | -0.51 26.09% | -0.61 | 0.10 | 15.87% |
| Q4 2021 Q2Q % growth | -0.70 1.41% | -0.65 | -0.05 | -8.44% |
| Q3 2021 Q2Q % growth | -0.65 -6.56% | -0.57 | -0.08 | -13.22% |
| Q2 2021 Q2Q % growth | -0.59 -25.53% | -0.51 | -0.08 | -15.30% |
| Q1 2021 Q2Q % growth | -0.69 -43.75% | -0.50 | -0.19 | -38.06% |
| Q4 2020 Q2Q % growth | -0.71 -61.36% | -0.59 | -0.12 | -19.67% |
| Q3 2020 Q2Q % growth | -0.61 11.59% | -0.42 | -0.19 | -44.69% |
| Q2 2020 Q2Q % growth | -0.47 -11.90% | -0.34 | -0.13 | -36.33% |
| Q1 2020 Q2Q % growth | -0.48 -11.63% | -0.37 | -0.11 | -31.45% |
| Q4 2019 Q2Q % growth | -0.44 | -0.47 | 0.03 | 5.81% |
| Q3 2019 Q2Q % growth | -0.69 | -0.34 | -0.35 | -100.44% |
| Q2 2019 Q2Q % growth | -0.42 | -0.41 | -0.01 | -1.25% |
| Q1 2019 Q2Q % growth | -0.43 | -0.44 | 0.01 | 3.09% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | 141.148M 92.13% | 150.33M | -9.182M | -6.11% |
| Q1 2025 Q2Q % growth | 120.856M 90.40% | 120.8M | 56K | 0.05% |
| Q4 2024 Q2Q % growth | 108.185M 146.04% | 101.95M | 6.235M | 6.12% |
| Q3 2024 Q2Q % growth | 83.879M -49.41% | 83.34M | 539K | 0.65% |
| Q2 2024 Q2Q % growth | 73.466M 357.05% | 67.21M | 6.256M | 9.31% |
| Q1 2024 Q2Q % growth | 63.474M 713.46% | 55.7M | 7.774M | 13.96% |
| Q4 2023 Q2Q % growth | 43.971M 54,863.75% | 40.865M | 3.106M | 7.60% |
| Q3 2023 Q2Q % growth | 165.815M 176,298.94% | 47.492M | 118.323M | 249.14% |
| Q2 2023 Q2Q % growth | 16.074M 2,606.06% | 17.802M | -1.728M | -9.71% |
| Q1 2023 Q2Q % growth | 7.803M 287.05% | 3.447M | 4.356M | 126.37% |
| Q4 2022 Q2Q % growth | 80K -96.55% | 1.864M | -1.784M | -95.71% |
| Q3 2022 Q2Q % growth | 94K -95.37% | 1.726M | -1.632M | -94.55% |
| Q2 2022 Q2Q % growth | 594K -61.55% | 202.643K | 391.357K | 193.13% |
| Q1 2022 Q2Q % growth | 2.016M 154.22% | 2.117M | -101K | -4.77% |
| Q4 2021 Q2Q % growth | 2.321M 6,007.89% | 2.281M | 40K | 1.75% |
| Q3 2021 Q2Q % growth | 2.03M 5,242.11% | 3.027M | -997K | -32.94% |
| Q2 2021 Q2Q % growth | 1.545M 3,965.79% | 3.559M | -2.014M | -56.59% |
| Q1 2021 Q2Q % growth | 793K 1,986.84% | 659.603K | 133.397K | 20.22% |
| Q4 2020 Q2Q % growth | 38K | 19.38K | 18.62K | 96.08% |
| Q3 2020 Q2Q % growth | 38K | 19.38K | 18.62K | 96.08% |
| Q2 2020 Q2Q % growth | 38K | 29.07K | 8.93K | 30.72% |
| Q1 2020 Q2Q % growth | 38K | 23.256K | 14.744K | 63.40% |
| Q4 2019 Q2Q % growth | 38K | 23.256K | 14.744K | 63.40% |
| Q3 2019 Q2Q % growth | 38K | 27.285K | 10.715K | 39.27% |
| Q2 2019 Q2Q % growth | 38K | 19.38K | 18.62K | 96.08% |
| Q1 2019 Q2Q % growth | 38K | 23.256K | 14.744K | 63.40% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | -13.23% | -35.86% | 0.64% | -8.49% |
| Revenue | 0.35% | -5.84% | -0.79% | -1.43% |